Jules Angst | |
---|---|
Born | [1] | 11 December 1926
Nationality | Swiss |
Citizenship | Switzerland |
Alma mater | University of Zurich |
Awards | Anna Monika Awards (1967/1969), Paul Martini Prize for Methodology in Medicine (1969), Otto Naegeli Prize (1983), Eric Stromgren Medal (1987), the Emil Kraepelin Medal of the Max Planck Institute, Munich (1992) Selo Prize NARSAD/Depression Research, USA (1994), Mogens Schou Award for Research in Bipolar Disorder, USA (2001), Burgholzli Award for Social Psychiatry (2001), Lifetime Achievement Award of the International Society of Psychiatric Genetics (2002), Lifetime Achievement Award (European Bipolar Forum), Wagner-Jauregg Medal (2007), ECNP Lifetime Achievement Award in Neuro-psychopharmacology (2012), Lifetime Achievement Award of the American Foundation for Suicide Prevention (2013), Joseph Zubin Award (APPA)(2015), Jean Delay Prize of the WPA (2017), Wilhelm Griesinger Medal of the DGPPN (German Association for Psychiatry, Psychotherapy and Psychosomatics) (2018) |
Scientific career | |
Fields | psychiatry |
Jules Angst (born 11 December 1926) is a Swiss academic who is Emeritus Professor of Psychiatry at Zurich University in Zurich, Switzerland, and Honorary Doctor of Heidelberg University in Heidelberg, Germany.
Angst was born in Zurich, where he also grew up. He completed his medical and psychiatric training in Zurich under his mentor, Professor Manfred Bleuler [2] (son and student of Eugen Bleuler). From 1969 to 1994, Jules Angst was Professor of Clinical Psychiatry in the University of Zurich Medical School and Head of the Research Department of Zurich University Psychiatric Hospital (the Burghölzli).
Jules Angst has continued uninterrupted his epidemiological and clinical research at the University (Universitatsklinik) since leaving his Chair. [3] He has remained the President of the European Bipolar Forum since 2003.
His scientific contributions include 15 books (as author and/or editor), 154 book chapters, and 539 journal articles. [4]
Jules Angst has received many awards in recognition of his work, including the Anna Monika Awards (1967/1969), Paul Martini Prize for Methodology in Medicine (1969), [5] Otto Naegeli Prize (1983), Eric Stromgren Medal (1987), the Emil Kraepelin Medal of the Max Planck Institute, Munich (1992), [6] the Jean Delay Prize of the World Psychiatric Association (2017), [7] and the Wilhelm Griesinger Medal of the DGPPN (German Association for Psychiatry, Psychotherapy and Psychosomatics (2018).
Other awards include the Selo Prize NARSAD/Depression Research, USA (1994), Mogens Schou Award for Research in Bipolar Disorder, USA (2001), [8] Burgholzli Award for Social Psychiatry (2001), the Lifetime Achievement Award of the International Society of Psychiatric Genetics (2002), Lifetime Achievement Award of the European Bipolar Forum (2006), the Wagner-Jauregg Medal (2007), ECNP Lifetime Achievement Award in Neuropsychopharmacology (2012), [9] Lifetime Achievement Award of the American Foundation for Suicide Prevention (2013), [10] and the Joseph Zubin Award of the American Psychopathological Association (2015). [11] In 1999, he was named Honorary Member of the European College of Neuropsychopharmacology (ECNP). [12]
Paul Eugen Bleuler was a Swiss psychiatrist and humanist most notable for his contributions to the understanding of mental illness. He coined several psychiatric terms including "schizophrenia", "schizoid", "autism", depth psychology and what Sigmund Freud called "Bleuler's happily chosen term ambivalence".
Gordon Barraclough Parker AO is an Australian psychiatrist who is scientia professor of psychiatry at the University of New South Wales (UNSW).
Hagop Souren Akiskal was a Lebanese-born American psychiatrist and professor, of Armenian descent. He is best known for his research on temperament and bipolar disorder, revolutionizing the field of clinical psychiatry.
Mogens Schou was a Danish psychiatrist whose research into lithium led to its utilization as a treatment for bipolar disorder.
Maximilian Fink is an American neurologist and psychiatrist best known for his work on ECT. His early work also included studies on the effect of psychoactive drugs on brain electrical activity; his later work has included books about the syndromes of catatonia and melancholia, published in the 2010s.
Guy Goodwin is a senior research fellow and until recently was the W.A. Handley Professor of Psychiatry at the University of Oxford (2014). A fellow of the Academy of Medical Sciences, Goodwin has served as principal investigator in many clinical trials for the treatment of bipolar disorder. He is also an Emeritus Senior Investigator at the National Institute for Health and Care Research (NIHR) and has been on the advisory boards of numerous research councils. He was President of the European College of Neuropsychopharmacology from 2013 to 2016.
Johan Cullberg was a Swedish professor in psychiatry and psychology, researcher, psychoanalyst, and author of a number of internationally recognised textbooks.
The Kraepelinian dichotomy is the division of the major endogenous psychoses into the disease concepts of dementia praecox, which was reformulated as schizophrenia by Eugen Bleuler by 1908, and manic-depressive psychosis, which has now been reconceived as bipolar disorder. This division was formally introduced in the sixth edition of Emil Kraepelin's psychiatric textbook Psychiatrie. Ein Lehrbuch für Studierende und Aerzte, published in 1899. It has been highly influential on modern psychiatric classification systems, the DSM and ICD, and is reflected in the taxonomic separation of schizophrenia from affective psychosis. However, there is also a diagnosis of schizoaffective disorder to cover cases that seem to show symptoms of both.
Manfred Bleuler was a Swiss physician and psychiatrist. Following in the footsteps of his father, doctoral supervisor, and colleague, Eugen Bleuler, Manfred Bleuler was devoted primarily to the study and treatment of schizophrenia. For his contributions, he received the Stanley R. Dean Award in 1970 and the Marcel Benoist Prize in 1972.
Eduard Vieta Pascual is a Catalan psychiatrist from Spain known for his work in the field of mood disorders. His unit is a world reference in clinical care, research and teaching of bipolar disorder and depression.
Wim van den Brink is emeritus Professor of Psychiatry and Addiction at the Academic Medical Center, University of Amsterdam. He was Director of the Amsterdam Institute for Addiction Research (AIAR) and Scientific Director of the National Committee for Treatment of Heroin Addiction (CCBH) in Utrecht, the Netherlands.
Hilary Patricia Blumberg is a medical doctor and the inaugural John and Hope Furth Professor of Psychiatry at the Yale School of Medicine. She is also a professor of Radiology and Biomedical Imaging, and works in the Child Study Center at Yale where she has been a faculty member since 1998. She attended Harvard University as an undergraduate, and completed medical school at Cornell University Medical College (1990). She completed her medical internship and psychiatry residency at Cornell University Medical College/New York Hospital, and her neuroimaging fellowship training at Cornell University, Weill Medical College. She has received the 2006 National Alliance for Research in Schizophrenia and Depression (NARSAD) and the Gerald L. Klerman Award for Clinical Research. Blumberg has authored a number of scientific articles that focus on bipolar disorder, neuroimaging, and effects of specific genetic variations, developmental trajectories and structure-function relationships.
Hans-Ulrich Wittchen is a clinical psychologist, psychotherapist and epidemiologist. He has been a head of the Institute of Clinical Psychology and Psychotherapy and the Center of Clinical Epidemiology and Longitudinal Studies (CELOS) at the Technische Universität Dresden. Since 2018, he is leading the research group "Clinical Psychology and Psychotherapy Research" at the Psychiatric Clinic of Ludwig-Maximilians-Universität München and directs the IAP-TU Dresden GmbH in Dresden.
Gregor Hasler is a Swiss psychiatry researcher, psychiatrist and psychotherapist. He is professor and chair of psychiatry and psychotherapy at the University of Fribourg in Switzerland. His research areas covers stress, depression, bipolar disorders, and eating disorders.
Andreas Meyer-Lindenberg is a German psychiatrist and professor in the Medical Faculty Mannheim at Heidelberg University. He is also the director and CEO of the Central Institute of Mental Health in Mannheim, as well as medical director of their Department of Psychiatry and Psychotherapy. His research includes work on the genetics of complex psychiatric disorders. He has also used neuroimaging to study the neurobiological basis of mental disorders such as Williams Syndrome, and the effects of living in urban areas on mental health and the human brain.
Prof. Robert Haim Belmaker, is an Israeli psychiatrist who has had major academic positions in Israeli psychiatry since 1974. He had a formative influence on biological directions in Israeli psychiatry. He was Hoffer-Vickar Professor of Psychiatry at Ben-Gurion University of the Negev, Beersheva Israel until his retirement and is now Emeritus.
Glenda Marlene MacQueen was a Canadian medical researcher and medical college professor and administrator. She was vice-dean of the Cumming School of Medicine at the University of Calgary from 2012 to 2019.
Marion Leboyer is a French psychiatrist, university professor and hospital practitioner at the Paris-Est Créteil University (UPEC).
Sir David Paul Brandes Goldberg was a British academic and social psychiatrist.
Iria Grande is a Spanish physician who is an associate professor of psychiatry at the University of Barcelona, a psychiatrist at Hospital Clínic, and a researcher at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM). She specializes in bipolar and depressive disorders and is affiliated with the Barcelona Bipolar and Depression Disorders Unit at Hospital Clínic. Since 2022, she has served as one of the councilors on the Executive Committee of the European College of Neuropsychopharmacology (ECNP) for the term 2022-2025.
{{cite web}}
: CS1 maint: archived copy as title (link)